CARE Ratings Issues Q2FY27 Monitoring Agency Report for Stallion India Fluorochemicals
Stallion India Fluorochemicals Ltd · Others (Uncategorized) · 14 Nov 2026, 10:33 pm
CARE Ratings Issues Q2FY27 Monitoring Agency Report for Stallion India Fluorochemicals CARE Ratings reported that out of Stallion India Fluorochemicals’ ₹160.73 crore IPO proceeds, ₹160.33 crore was utilized through 30th Sep'26, leaving ₹0.40 crore parked in an ICICI Bank fixed deposit maturing 10th Mar'27. A minor deviation of ₹0.40 crore occurred as the company counted internal funds toward IPO objects. Furthermore, capex at the Mambattu facility experienced delays and cost overruns due to capacity doubling, now targeted for completion by Jan'27 funded via internal accruals. Capex at the Khalapur plant concluded with a 334-day delay.
Original exchange filing (PDF)
More announcements from Stallion India Fluorochemicals Ltd
- As per the attachment · 17 Nov 2026
- Intimation regarding Q2 & H1 FY 2026-27 Earnings Conference Call · 19 Nov 2026
- As per attachment. · 16 Nov 2026
- As per the attachment. · 15 Nov 2026
- Stallion India Fluorochemicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 13 Nov 2026
- Outcome of Board Meeting held on 13th November, 2026 - Approval of Unaudited Financial Results for the Quarter and Half Year Ended September 30, 2026. · 13 Nov 2026
- Stallion India Fluorochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve As per attachment. · 13 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 13 Nov 2026
